These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 1691795

  • 1. [Sweet's syndrome in patient with refractory anemia during recombinant human granulocyte colony stimulating factor therapy].
    Sai M, Kawanishi Y, Itoh Y, Aizawa S, Kawashima T, Koga M, Kuratsuji T, Toyama K.
    Rinsho Ketsueki; 1990 Feb; 31(2):245-8. PubMed ID: 1691795
    [Abstract] [Full Text] [Related]

  • 2. [Sweet's syndrome in a patient with chronic myeloproliferative disorder during recombinant human granulocyte colony stimulating factor therapy].
    Shiga Y, Shichishima T, Kamei K, Watanabe K, Ishibashi T, Maruyama Y.
    Rinsho Ketsueki; 1995 Apr; 36(4):353-8. PubMed ID: 7540225
    [Abstract] [Full Text] [Related]

  • 3. [Appearance of Sweet's syndrome in a patient with myelodysplastic syndrome (MDS) without relation to the hematological findings of MDS].
    Hasegawa Y, Tomiyama J, Ninomiya H, Abe T.
    Rinsho Ketsueki; 1989 Jun; 30(6):863-7. PubMed ID: 2795896
    [Abstract] [Full Text] [Related]

  • 4. Sweet's syndrome associated with granulocyte colony-stimulating factor.
    Hasegawa M, Sato S, Nakada M, Nitta H, Shirasaki H, Kasahara K, Takehara K.
    Eur J Dermatol; 1998 Jun; 8(7):503-5. PubMed ID: 9854164
    [Abstract] [Full Text] [Related]

  • 5. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.
    Teshima H, Ishikawa J, Kitayama H, Yamagami T, Hiraoka A, Nakamura H, Shibata H, Masaoka T, Takaku F.
    Exp Hematol; 1989 Sep; 17(8):853-8. PubMed ID: 2475358
    [Abstract] [Full Text] [Related]

  • 6. Sweet's syndrome in chronic lymphocytic leukemia associated with neutropenic fever and granulocyte colony stimulation factor.
    Thompson MA, Dyson SW, Faderl S.
    Am J Hematol; 2006 Sep; 81(9):703-5. PubMed ID: 16838322
    [Abstract] [Full Text] [Related]

  • 7. [Neutrophilic dermatosis in a patient with refractory anemia].
    Banno S, Nitta M, Wakita A, Iwaki O, Takada K, Mitomo Y, Yamamoto M, Morita A, Tsuji T, Kunimatsu M.
    Rinsho Ketsueki; 1992 May; 33(5):700-5. PubMed ID: 1630024
    [Abstract] [Full Text] [Related]

  • 8. [Sweet syndrome following therapeutic use of granulocyte colony stimulating factor].
    Veres K, Haraszti A, Nemes Z, Zeher M.
    Orv Hetil; 1999 May 09; 140(19):1059-61. PubMed ID: 10339998
    [Abstract] [Full Text] [Related]

  • 9. [Sequential treatment with granulocyte-colony stimulating factor (GCSF) and human recombinant erythropoietin (rH-EPO) in anemia of a patient with myelodysplastic syndrome and high blood transfusion requirements)].
    Borbolla-Escoboza JR, González-Avante CM, López-Hernández MA, Flores-Chapa JD, Collados-Larumbe MT.
    Gac Med Mex; 1997 May 09; 133(4):355-9. PubMed ID: 9410796
    [Abstract] [Full Text] [Related]

  • 10. [Acute febrile neutrophilic dermatosis (Sweet's syndrome) in a patient with agnogenic myeloid metaplasia].
    Suzuki K, Utsumi H, Yamamoto K, Kamiyama T, Szuzki T, Miura O, Maruyama Y, Kato A, Murakami N, Murohashi I.
    Rinsho Ketsueki; 1989 Feb 09; 30(2):202-6. PubMed ID: 2746875
    [Abstract] [Full Text] [Related]

  • 11. [Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].
    Fukutani H, Ogawa M, Horikoshi N, Inoue K, Mukaiyama T, Nagamine D, Shinagawa K, Tabata M, Hirano A, Mizunuma N.
    Gan To Kagaku Ryoho; 1989 May 09; 16(5):2005-12. PubMed ID: 2471461
    [Abstract] [Full Text] [Related]

  • 12. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K, Inoue S, Kumar A.
    Exp Hematol; 1991 Jun 09; 19(5):352-8. PubMed ID: 1709109
    [Abstract] [Full Text] [Related]

  • 13. [Changes in neutrophil counts and functions after the administration of recombinant human granulocyte colony-stimulating factor in a patient with chronic idiopathic neutropenia].
    Sai M, Kawanishi Y, Kuriyama K, Kuratsuji T, Toyama K.
    Rinsho Ketsueki; 1990 Apr 09; 31(4):484-6. PubMed ID: 1696326
    [Abstract] [Full Text] [Related]

  • 14. [Sweet's syndrome associated with myelodysplastic syndrome].
    Furukawa Y, Inoue T, Yamane T, Hiyoshi M, Sasaki A, Kishida T, Kojima K, Im T, Tatsumi N.
    Rinsho Ketsueki; 1989 May 09; 30(5):764-7. PubMed ID: 2795888
    [Abstract] [Full Text] [Related]

  • 15. Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome.
    Hazar V, Ongun H, Yeşilipek MA, Yeğin O.
    Turk J Pediatr; 1999 May 09; 41(1):117-20. PubMed ID: 10770686
    [Abstract] [Full Text] [Related]

  • 16. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in patients with aplastic anemia and refractory anemia.
    Bessho M, Jinnai I, Hirashima K, Saito M, Murohashi I, Ino H, Tsuji M, Fukuda M, Maruyama M, Kusumoto S.
    Stem Cells; 1994 Nov 09; 12(6):604-15. PubMed ID: 7533579
    [Abstract] [Full Text] [Related]

  • 17. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
    Balleari E, Rossi E, Clavio M, Congiu A, Gobbi M, Grosso M, Secondo V, Spriano M, Timitilli S, Ghio R.
    Ann Hematol; 2006 Mar 09; 85(3):174-80. PubMed ID: 16408206
    [Abstract] [Full Text] [Related]

  • 18. Clinical studies with granulocyte colony stimulating factor (G-CSF) in patients receiving cytotoxic chemotherapy.
    Morstyn G, Campbell L, Dührsen U, Souza LM, Alton NK, Villeval JL, Nicola NA, Boyd AW, Kannourakis G, Cebon J.
    Behring Inst Mitt; 1988 Aug 09; (83):234-9. PubMed ID: 2467651
    [Abstract] [Full Text] [Related]

  • 19. Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group.
    Remacha AF, Arrizabalaga B, Villegas A, Manteiga R, Calvo T, Julià A, Fernández Fuertes I, González FA, Font L, Juncà J, del Arco A, Malcorra JJ, Equiza EP, de Mendiguren BP, Romero M.
    Haematologica; 1999 Dec 09; 84(12):1058-64. PubMed ID: 10586205
    [Abstract] [Full Text] [Related]

  • 20. A new bioassay for human granulocyte colony-stimulating factor (hG-CSF) using murine myeloblastic NFS-60 cells as targets and estimation of its levels in sera from normal healthy persons and patients with infectious and hematological disorders.
    Shirafuji N, Asano S, Matsuda S, Watari K, Takaku F, Nagata S.
    Exp Hematol; 1989 Feb 09; 17(2):116-9. PubMed ID: 2463930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.